_ Abstract 1. Basic underlying view
Mycobacterium tuberculosis
Table 1 2. LTBI treatment subjects 1. Basic view
2. TB development risk factors and infection diagnosis i. HIV/AIDS ii. Hemodialysis for chronic renal failure, and kidney transplant recipients iii. Recipients of other transplanted organs and stem cell transplants iv. Diabetes
i. Biologics
ii. Corticosteroids iii. Other immunosuppressants i. Healed TB lesions in chest radiography ii. Silicosis iii. Weight iv. Smoking
v. Being from a high-prevalence country vi. Healthcare workers 3. Actual application of treatment 4. Topics for future investigation
3. Treatment 1. Drugs and administration periods a. Effects of INH for immunocompetent individuals b. Effects of INH for immunosuppressed individuals Table 2
Table 3 a. Effects of RFP b. Use of INH versus RFP 2. Irregular administration of treatment
3. Daily dose 4. Contact with INH- and RFP-resistant TB 5. Managing side effects 6. Monitoring of TB development during treatment 7. Health education
8. Medication adherence support 9. Post-treatment risk of TB development, and approaches to follow-up observation Reference material Mycobacterium tuberculosis
10. LTBI retreatment 11. Future topics related to treatment 4. Related systems
References Mycobacterium tuberculosis
M.tuberculosis Mycobacterium tuberculosis
Mycobacterium tuberculosis